A Message from the IRIS Program
IRIS Program Outlook
February 2022

The IRIS Program is committed to producing assessments in a timely and transparent manner. Table 1
describes assessments that are currently in development and their projected public release dates. The
IRIS Program is providing this information so that stakeholders are aware of upcoming assessment
products, and to allow the public and research community an opportunity to communicate relevant
research to EPA. The documents listed in Table 1 can be found at Regulations.gov in the IRIS public
comment dockets. Docket numbers are listed on the IRIS website here: https://iris.epa.gov/Dockets/.
While IRIS assessments are not associated with proposed rulemaking, Regulations.gov serves as both an
internal portal to facilitate public comment and as a document repository for Federal government
agencies.

Projected dates are based on factors such as the 1) scope of the assessment (e.g., size and complexity of
a chemical's evidence base)1 and 2) resource availability. Nearer-term activities are estimated using
current Fiscal Year (FY) and Quarter. Long-term milestones are projected only for the FY due to the
increased uncertainty of projecting timelines at the Quarter level. While projected dates reflect the IRIS
Program's best estimate at this time based on available information, they are subject to change.

Changes to estimated dates typically result from additional time needed to address the scientific
challenges unique to each chemical assessment, new data, or respond to internal, public, and/or peer
review comments, in addition to current EPA priorities and the availability of staff with the appropriate
expertise to address those challenges. The IRIS Program Outlook is updated at least three times each
calendar year (February, June, October).

Additional information regarding other pertinent products relating to IRIS assessments and IRIS Program
activities is included in Tables 2 and 3. For questions regarding the IRIS Program activities, visit the
Contact Us page on the EPA Website. For press inquiries, visit EPA's Office of Public Affairs website.

' The scope of IRIS assessments is discussed in the IRIS Assessment Plan (IAP). Information regarding size of the

evidence base and expected key areas of scientific complexity is available in these documents. For information on
how lAPs are developed, please see the IRIS Handbook:

https://cfpub.epa.gov/ncea/iris drafts/recordisplay.cfm?deid=350086.

1


-------
Table 1. IRIS Assessment Products/Activities - February 2022.

Assessment

Public Product(s)/Activity

Projected Date

Arsenic, Inorganic

Systematic Review Protocol

Released on May 23, 2019 for a 30-day public



comment period until June 27, 2019.
If ew meeting July 16, 2019.

Public Comment Draft Release

FY23 Q1

External Peer Review

FY23

Chloroform (Inhalation)1

IRIS Assessment Plan

Released on September 18, 2017 for a 30-day



public comment period until October 18, 2017.
Public Science Meeting on September 27, 2017.

Systematic Review Protocol

Released on January 31, 2018 for a 30-day public

comment period until March 2, 2018.

Public Comment Draft

FY22 Q4

External Peer Review

FY23 Q1

Chromium VI

Systematic Review Protocol

Released on March 15, 2019 for a 45-day public
comment period until April 29, 2019.

Public Science Meeting on April 24, 2019.

Public Comment Draft Release

FY22 Q4

External Peer Review

FY23 Q1

Ethvlbenzene1,2

IRIS Assessment Plan

Released on September 18, r a 30-day
Public Science Meeting on September 27, 2017.

Systematic Review Protocol

FY22 Q3

Public Comment Draft Release

TBD

External Peer Review

TBD

Formaldehyde1

Public Comment Draft Release

FY22 Q3

External Peer Review

FY22 Q3

2


-------
Assessment

Public Product(s)/Activity

Projected Date

Inorganic Mercury salts

IRIS Assessment Plan

Released on October 8, 2019 for a 30-dav public
comment period until November 7, 2019.

Public science meeting on December 5, 2019



Systematic Review Protocol

Released on March 11, 2021 for a 30-dav public
comment period until April 12, 2021.



Public Comment Draft Release

FY23



External Peer Review

FY23

Methvlmercurv

IRIS Assessment Plan

Released on April 4, 2019 for a 30-dav public
comment period until May 6, 2019.

Public Science Meeting on May 15, 2019



Systematic Review Protocol

Released on Mav 28, 2020 for a 45-dav public
comment period until Julv 13, 2020.



Public Comment Draft Release

FY23



External Peer Review

FY24

Naphthalene1,2

IRIS Assessment Plan

Released on Julv 5, 2018 for a 30-dav public





comment period until August 6, 2018; extended
until September 5, 2018.





Public Science meeting originally scheduled for
August 23, 2018 was postponed and held
November 9, 2,021.



Systematic Review Protocol

FY22 Q4



Public Comment Draft Release

TBD



External Peer Review

TBD

Perfluorobutanoic Acid fPFBA)3

Systematic Review Protocol

Released on November 8, 2019 for a 45-dav
comment period until December 23, 2019.



Public Comment Draft Release

Released on August 23, 2021 for a 60-day public
comment period until October 22, 2021; extended
until November 8, 2021.



External Peer Review

FY22 Ql; see Table 2 for details

Perfluorodecanoic Acid (PFDA)3

Systematic Review Protocol

Released on November 8, 2019 for a 45-dav public
comment period until December 23, 2019.

3


-------
Assessment

Public Product(s)/Activity

Projected Date



Public Comment Draft Release

FY23 Q1

External Peer Review

FY23 Q2

Perfluorohexanoic acid fPFHxA)3

Systematic Review Protocol

Released on November 8, 2019 for a 45-day public



comment period until December 23, 2019.

Public Comment Draft Release

Released on February 2, 2022 for a 60-dav public
comment period until April 4, 2022.

External Peer Review

FY22 Q3

Perfluorohexanesulforiic Acid

Systematic Review Protocol

Released on November 8, 2019 for a 45-day public

{PFHxS}3

comment period until December 23, 2019.



Public Comment Draft Release

FY23 Q2

External Peer Review

FY23 Q2

Perfluorononanoic Acid fPFNA)3

Systematic Review Protocol

Released on November 8, 2019 for a 45-day public



comment period until December 23, 2019.

Public Comment Draft Release

FY23 Q2

External Peer Review

FY23 Q3

Polvchlorinated Biphenvls
(PCBs; oral, noncancer)

Systematic Review Protocol

Released on December 19, 2019 for a 30-day public
comment period until January 21, 2020.

Public Comment Draft Release

FY24

External Peer Review

FY25

Uranium1,2

IRIS Assessment Plan

Released on January 31, 2018 for a 30-day public
comment period until March 2, 2018.

Public Science Meeting on March 22, 2018

Systematic Review Protocol

FY22 Q4

Public Comment Draft Release

TBD

External Peer Review

TBD

Vanadium and Compounds (Oral)

IRIS Assessment Plan

Released on July 24, 2020 for a 30-day comment
period until August 24, 2020. Extended until
September 23, 2020.

Public Science Meeting on August 19, 2020

4


-------
Assessment

Public Product(s)/Activity

Projected Date



Systematic Review Protocol

Released on April 26, 2021 for a 30-dav public
comment period until May 26, 2021.

Public Comment Draft Release

FY24

External Peer Review

FY24

Vanadium and Compounds

IRIS Assessment Plan

Released on May 28, 2021 for a 30-dav public

(Inhalation)2

comment period until June 28, 2021.



Public Science Meeting on July 14, 2021.

Systematic Review Protocol

FY22 Q3

Public Comment Draft Release

TBD

External Peer Review

TBD

^he chloroform, ethylbenzene, formaldehyde, naphthalene, and uranium IRIS assessments were suspended in April 2019 due to
realignment of Agency priorities, see April 2019 IRIS Program Outlook here:

https://cfpub,epa.gov/ncea/iris drafts/recordisplay,cfm?deid=350410. Chloroform was later identified as a priority; see February
2020 IRIS Program Outlook, here: https://www.epa,goy/sites/default/files/2020-02/docuroents/iris program outlook feb2020.pdf.
Formaldehyde was also later identified as a priority, while naphthalene, ethylbenzene, and uranium were nominated in FY21 and are
currently in progress; see June 2021 IRIS Program Outlooks here: https://www.epa,gov/systero/files/docuroents/2021~0y/iris-
program-outlook-iune-2021.pdf.

2The IRIS Program is currently revising the ORD Staff Handbook for Developing IRIS Assessments ("IRIS Handbook") following external
peer review by the National Academy of Sciences, which is expected to impact systematic review protocol development
(ethylbenzene, naphthalene, uranium, vanadium inhalation). Following the systematic review protocol release, subsequent projected
milestone dates (public comment and peer review) will be updated and provided in the next IRIS Program Outlook.

3The five per- and polyfluoroalkyl Substances (PFAS) assessments are being developed according to the scope and methods outlined in
the publicly posted systematic review protocol (https://cfpub.epa.gov/ncea/iris drafts/recordisplay.cfm?deid=345065) and build
upon several other PFAS assessments that have already been developed. These assessments represent only one component of the
broader EPA 2021 StrategicRoad map currently being implemented at the U.S. EPA, located at https://www.epa.gov/pfas/pfas-
strategic-roadmap-epas-commitments-action-2021-2024.

5


-------
Table 2. Upcoming IRIS Assessment support products and activities

Product or Activity

Next Anticipated Public Step(s)

Projected Date

ORD Staff Handbook for Developing IRIS Assessments
("IRIS Handbook")

Final

FY22 0.4/ FY23 Q1

NAS Workshop - Advances Made During Application of
Artificial Intelligence and Open Data Practices in Chemical
Hazard Assessment

Public Workshop

May 25-26, 2022

NAS Workshop - Triangulation of Evidence in
Environmental Epidemiology

Public Workshop

May 9, 2022 and May 11, 2022

PCB Mixtures/Modeling and Tool Webinar

Public Meeting

March 16, 2022

Peer Review Activities

Perfluorobutanoic Acid fPFBA)

Public External Peer Review Meeting

February 22-23, 2022

Perfluorohexanoic acid {PFHxAl

Public External Peer Review Meeting

FY22 Q3

Formaldehyde

Public External Peer Review Meeting

FY22 Q3

Table 3. Select Recent Publications Related to IRIS Assessment Activities

Assessment

Citation

Publication Date

Polychlorinated Biphenyls
(PCBs; oral, noncancer)

Weitekamp, C.A., Phillips, L.J., Carlson, L.M., DeLuca, N.M., Cohen Hubal,
E.A., Lehmann, G.M. (2021). A state-of-the-science review of
polychlorinated biphenyl exposures at background levels: Relative
contributions of exposure routes, Science of the Total Environment, 776(1).
145912. https://doi.Org/10.1016/j.scitotenv.2021.145912

Published February 2021

6


-------